Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization



Status:Active, not recruiting
Conditions:Contraception, Contraception, Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:18 - 50
Updated:1/11/2019
Start Date:September 30, 2018
End Date:January 31, 2020

Use our guide to learn which trials are right for you!

More than 345,000 U.S. women undergo either tubal ligation ("getting her tubes tied") or
Essure procedures each year to permanently avoid pregnancy. Both prevent pregnancy by
blocking women's Fallopian tubes but neither are 100% effective. Both can have complications,
but not enough is known to help women make an informed choice between the two.

Essure is popular because it can be performed without anesthesia in a doctor's office and
women can return to work the next day. However, patients have reported that the Essure
procedure was unexpectedly painful. Also, women need to use other contraceptives for 3 months
and then return for testing, to make sure their tubes are blocked and will prevent pregnancy.
Not all women return for this test and some may get pregnant before realizing their Essure
didn't work.

Essure was approved by the Food and Drug Administration (FDA) in 2002, but no studies ever
compared it to tubal ligation. By 2015, over 9,000 women reported serious complications to
the FDA. Women who were unhappy with Essure found each other online and created a Facebook
"Essure Problems" support group that now has over 31,000 members. After an FDA Advisory Board
expressed concerns about Essure's risks, in 2016 the FDA required stronger warnings about
complications and announced that "more rigorous research" was needed, demanding Essure's
maker conduct a new study comparing the benefits and risks of Essure to tubal ligation.
Unfortunately, that study will not be finished before September 2023.

To provide answers as rapidly as possible for women considering sterilization, we will
analyze data from the medical records of thousands of women with sterilization procedures
funded by California's Medicaid. As poor women and women of color have different experiences
with healthcare, and they more often choose sterilization, comparing these women's
experiences with Essure and tubal ligation is very important. We will compare the safety and
effectiveness of the 2 sterilization procedures to answer:

- How many women got pregnant afterwards?

- How many operations did each woman need to become infertile?

- Which complications did women have (i.e. chronic pain, depression)? We will also check
whether certain women (such as certain age groups or those with diabetes) were most
likely to have problems after either procedure.

Study Aims:

Aim 1. To compare the real world effectiveness of hysteroscopic sterilization, laparoscopic
sterilization and intrauterine devices (IUDs) by calculating:

1. Pregnancy rates at 3, 6, 12, 24, 36, 48, and 60 months post-procedure, indicating
sterilization failure.

2. Patient's ability to rely on sterilization after hysteroscopic sterilization (blocked
tubes on hysterosalpingogram) compared to laparoscopic sterilization and IUDs at 3, 6,
12, 24, 36, 48, and 60 months post-procedure, indicating concern of sterilization
failure.

Aim 2. To compare safety and complications after hysteroscopic sterilization laparoscopic
sterilization, and IUD placement by:

1. Evaluating rates of reoperation to achieve sterilization or reinsertion to achieve IUD
placement at 3, 6, 12, 24, 36, 48, and 60 months post-procedure.

2. Evaluating other outcomes suggested by patient partners, including additional surgeries
due to complications, chronic pain, and/or depression, by measuring claims for narcotic
prescriptions, and antidepressants at 3, 6, 12, 24, 36, 48, 60 months post-procedure
(hysteroscopic sterilization, laparoscopic sterilization, or IUD placement).

3. Identify sociodemographic and pre-sterilization clinical variables which may predict
complications following hysteroscopic sterilization compared to laparoscopic
sterilization and to IUDs.

Inclusion Criteria:

- Women aged 18-50 years at the time of sterilization procedure

- Claims indicating hysteroscopic or laparoscopic sterilization procedures or IUD
placement

Exclusion Criteria:

- Active cancer

- Any conditions that would have excluded the patient for hysteroscopic sterilization

- Any conditions that would have excluded the patient for laparoscopic sterilization
We found this trial at
1
site
333 Cedar St
New Haven, Connecticut 06504
(203) 432-4771
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
?
mi
from
New Haven, CT
Click here to add this to my saved trials